Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterization of risk single nucleotide polymorphism associated long noncoding RNA in prostate cancer
FY 2014-15
Summary
Prostate cancer is the most commonly diagnosed cancer and the third leading cause of cancer mortality in Canadian men. The most widely used diagnostic test using the diagnosis marker Prostate-specific antigen (PSA) leads to the overdiagnosis of prostate cancer. In addition, it also fails to distinguish between the aggressive and non-aggressive form of prostate cancer. These problems will lead to the overtreatment of patients with the non-aggressive form, while delaying proper treatments to patients with the aggressive form. Therefore, a major goal for the field of prostate cancer research is to discover more precise biomarkers for prostate cancer diagnosis and prognosis. Genome-wide Association Studies (GWAS) has characterized thousands of prostate cancer risk single nucleotide polymorphism (SNP) and a few of them are associated with prostate cancer aggressiveness. Our computational analysis identified an aggressiveness associated risk SNP located in the promoter region of a long noncoding RNA PCAT19. Our proposed study will investigate the effect of risk SNPs on PCAT19 dysregulation, the functional role and mechanism of PCAT19 in prostate cancer, and its clinical relevance. The results from our study will shed light on the association between risk SNP and lncRNA in prostate cancer. In addition, it may also initiate clinical studies to evaluate PCAT19 as a potential novel biomarker or therapeutic target for prostate cancer.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331269
Name
Hua Jun Jie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of risk single nucleotide polymorphism associated long noncoding RNA in prostate cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker; Epigenetics; Long Non-Coding Rna; Molecular Biology; Prostate Cancer; Single Nucleotide Polymorphism
Abstract
Prostate cancer is the most commonly diagnosed cancer and the third leading cause of cancer mortality in Canadian men. The most widely used diagnostic test using the diagnosis marker Prostate-specific antigen (PSA) leads to the overdiagnosis of prostate cancer. In addition, it also fails to distinguish between the aggressive and non-aggressive form of prostate cancer. These problems will lead to the overtreatment of patients with the non-aggressive form, while delaying proper treatments to patients with the aggressive form. Therefore, a major goal for the field of prostate cancer research is to discover more precise biomarkers for prostate cancer diagnosis and prognosis. Genome-wide Association Studies (GWAS) has characterized thousands of prostate cancer risk single nucleotide polymorphism (SNP) and a few of them are associated with prostate cancer aggressiveness. Our computational analysis identified an aggressiveness associated risk SNP located in the promoter region of a long noncoding RNA PCAT19. Our proposed study will investigate the effect of risk SNPs on PCAT19 dysregulation, the functional role and mechanism of PCAT19 in prostate cancer, and its clinical relevance. The results from our study will shed light on the association between risk SNP and lncRNA in prostate cancer. In addition, it may also initiate clinical studies to evaluate PCAT19 as a potential novel biomarker or therapeutic target for prostate cancer.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hua, Jun Jie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~